Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456346
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-06-07
Brief Title:
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia MK-3543-007
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-05-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05-14
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-07
First Submit QC Date:
June 7 2024
Study First Post Date:
2024-06-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL